Bukwang Pharmaceutical said Friday its third-quarter consolidated operating profit rose 120.7 percent year-on-year to 2.16 billion won ($1.63 million).

Revenue for the same period climbed 21.2 percent to 57.97 billion won.

Net profit for the period fell 43.3 percent to 847 million won, according to preliminary figures.


jiyoon436@heraldcorp.com